Health Condition 1: N921- Excessive and frequent menstruation with irregular cycle
Conditions
Interventions
Intervention1: Levonorgestrel intrauterine system: 52mg total dose releases 26microgram per day inserted for 6 months
Control Intervention1: NIL: NIL
Sponsors
Dr Monisha S
Eligibility
Inclusion criteria
Inclusion criteria: Clinical diagnosis of heavy menstrual bleeding Uterine size less than 14 weeks Multiparous women Failed oral medications Willing to give informed consent
Exclusion criteria
Exclusion criteria: Congenital or acquired uterine anomalies Submucous fibroid distorting the uterine cavity Uterine size more than 14 weeks Acute pelvic inflammatory disease Malignancy or suspected endometrial cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pictorial blood assessment chart PBAC score and HemoglobinTimepoint: At insertion and 3 months and 6 months post insertion of levonorgestrel intrauterine system | — |
Secondary
| Measure | Time frame |
|---|---|
| Endometrial thicknessTimepoint: At insertion and 3months and 6 months post insertion of levonorgestrel intrauterine system;Resistance index and pulsatility index of arcuate and radial arteriesTimepoint: At insertion and 3 months and 6 months post insertion of levonorgestrel intrauterine system | — |
Countries
India
Contacts
Public ContactDr Shriram N
JR Medical College and Hospital
Outcome results
None listed